Recombinant multi-species PBXIP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PBXIP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene interacts with the PBX1 homeodomain protein, inhibiting its transcriptional activation potential by preventing its binding to DNA. The encoded protein, which is primarily cytosolic but can shuttle to the nucleus, also can interact with estrogen receptors alpha and beta and promote the proliferation of breast cancer, brain tumors, and lung cancer. Several transcript variants encoding different isoforms have been found for this gene. More variants exist, but their full-length natures have yet to be determined. [provided by RefSeq, Dec 2015]
The Alternative Names of target: PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Hematopoietic PBX-interacting protein,HPIP
Go
to PBXIP1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1327-Ab-1/ GM-Tg-hg-IP1327-Ab-2 | Human PBXIP1 protein | Human |
GM-Tg-rg-IP1327-Ab-1/ GM-Tg-rg-IP1327-Ab-2 | Rat PBXIP1 protein | Rat |
GM-Tg-mg-IP1327-Ab-1/ GM-Tg-mg-IP1327-Ab-2 | Mouse PBXIP1 protein | Mouse |
GM-Tg-cynog-IP1327-Ab-1/ GM-Tg-cynog-IP1327-Ab-2 | Cynomolgus/Rhesus macaque PBXIP1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1327-Ab-1/ GM-Tg-felg-IP1327-Ab-2 | Feline PBXIP1 protein | Feline |
GM-Tg-cang-IP1327-Ab-1/ GM-Tg-cang-IP1327-Ab-2 | Canine PBXIP1 protein | Canine |
GM-Tg-bovg-IP1327-Ab-1/ GM-Tg-bovg-IP1327-Ab-2 | Bovine PBXIP1 protein | Bovine |
GM-Tg-equg-IP1327-Ab-1/ GM-Tg-equg-IP1327-Ab-2 | Equine PBXIP1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP1327-Ab-1/ GM-Tg-hg-IP1327-Ab-2;
GM-Tg-rg-IP1327-Ab-1/ GM-Tg-rg-IP1327-Ab-2;
GM-Tg-mg-IP1327-Ab-1/ GM-Tg-mg-IP1327-Ab-2; GM-Tg-cynog-IP1327-Ab-1/ GM-Tg-cynog-IP1327-Ab-2; GM-Tg-felg-IP1327-Ab-1/ GM-Tg-felg-IP1327-Ab-2; GM-Tg-cang-IP1327-Ab-1/ GM-Tg-cang-IP1327-Ab-2; GM-Tg-bovg-IP1327-Ab-1/ GM-Tg-bovg-IP1327-Ab-2; GM-Tg-equg-IP1327-Ab-1/ GM-Tg-equg-IP1327-Ab-2 |
Products Name | PBXIP1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | PBXIP1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PBXIP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.